\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\.\\ \\(fundoscopic\\ examination\\ not\\ done\\.\\)\ \(0\)\
\-\ third\\ ventriculostomy\ \(3\)\
\-\ \\â\\€\\¢\\ ct\\:\\ dilated\\ lateral\\ and\\ third\\ ventricles\ \(0\)\
\-\ \\â\\€\\¢\\ mri\\:\\ dilated\\ lateral\\ and\\ third\\ ventricles\ \(0\)\
\-\ \\â\\€\\¢\\ mass\\ lesion\\ tectal\\ plate\\ which\\ is\\ hyperintense\\ on\\ t2\\ and\\ flair\\ sequences\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ pathologic\\ enhancement\\.\ \(0\)\
\-\ tectal\\ plate\\ glioma\ \(0\)\
\-\ \\â\\€\\¢\\ tectal\\ glioma\\ \\(astrocytoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ pineal\\ region\\ mass\\ \\(germ\\ cell\\ tumor\\,\\ pineocytoma\\,\\ pineoblastoma\\)\ \(0\)\
\-\ 27\\ year\\ old\\ woman\\ with\\ a\\ one\\ year\\ history\\ of\\ headache\\ and\\ intermittent\\ visual\\ problems\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tectal\\:\\ 0\\.22705877131303354\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1408552226153607\ \(0\)\
\-\ third\\:\\ 0\\.11549820317359541\ \(0\)\
\-\ plate\\:\\ 0\\.09624536923175825\ \(0\)\
\-\ ventricles\\:\\ 0\\.09033096355887094\ \(0\)\
\-\ glioma\\:\\ 0\\.08657693918441776\ \(0\)\
\-\ pineocytoma\\:\\ 0\\.07436285220932896\ \(0\)\
\-\ pineoblastoma\\:\\ 0\\.07317902619070171\ \(0\)\
\-\ ventriculostomy\\:\\ 0\\.0721081252940239\ \(0\)\
\-\ fundoscopic\\:\\ 0\\.07023111310679732\ \(0\)\
\-\ dilated\\:\\ 0\\.06977733497958716\ \(0\)\
\-\ pineal\\:\\ 0\\.06010991596816597\ \(0\)\
\-\ germ\\:\\ 0\\.04967493561004561\ \(0\)\
\-\ 27\\:\\ 0\\.04453357483198742\ \(0\)\
\-\ problems\\:\\ 0\\.04444613505173962\ \(0\)\
\-\ flair\\:\\ 0\\.044018860943995354\ \(0\)\
\-\ visual\\:\\ 0\\.043526696644462855\ \(0\)\
\-\ pathologic\\:\\ 0\\.04202634391834462\ \(0\)\
\-\ lateral\\:\\ 0\\.04149815832864158\ \(0\)\
\-\ intermittent\\:\\ 0\\.04121375221520275\ \(0\)\
\-\ sequences\\:\\ 0\\.04009544215512373\ \(0\)\
\-\ hyperintense\\:\\ 0\\.039861351291046856\ \(0\)\
\-\ done\\:\\ 0\\.03980358275733428\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.03728483369295838\ \(0\)\
\-\ headache\\:\\ 0\\.032977364467031436\ \(0\)\
\-\ examination\\:\\ 0\\.029847449836792866\ \(0\)\
\-\ negative\\:\\ 0\\.028675507431178363\ \(0\)\
\-\ lymphoma\\:\\ 0\\.027440434094263885\ \(0\)\
\-\ t2\\:\\ 0\\.027175154705060135\ \(0\)\
\-\ region\\:\\ 0\\.027119114912801265\ \(0\)\
\-\ mass\\:\\ 0\\.02670698892016999\ \(0\)\
\-\ one\\:\\ 0\\.026019453745063415\ \(0\)\
\-\ cell\\:\\ 0\\.025935288894174003\ \(0\)\
\-\ enhancement\\:\\ 0\\.0257358288328431\ \(0\)\
\-\ \\:\\:\\ 0\\.025399434067205955\ \(0\)\
\-\ \\(\\:\\ 0\\.024349271671141367\ \(0\)\
\-\ metastatic\\:\\ 0\\.02416976857995607\ \(0\)\
\-\ \\)\\:\\ 0\\.024051832318426013\ \(0\)\
\-\ tumor\\:\\ 0\\.022384632602368663\ \(0\)\
\-\ woman\\:\\ 0\\.022178684803246137\ \(0\)\
\-\ mri\\:\\ 0\\.02205927926870359\ \(0\)\
\-\ year\\:\\ 0\\.021485511669054262\ \(0\)\
\-\ lesion\\:\\ 0\\.01955680029213994\ \(0\)\
\-\ which\\:\\ 0\\.017922972890365714\ \(0\)\
\-\ disease\\:\\ 0\\.015693680238378697\ \(0\)\
\-\ not\\:\\ 0\\.013874367098223993\ \(0\)\
\-\ ct\\:\\ 0\\.013430378128000482\ \(0\)\
\-\ history\\:\\ 0\\.01326083750232678\ \(0\)\
\-\ old\\:\\ 0\\.009830725807441062\ \(0\)\
\-\ no\\:\\ 0\\.009667911805660696\ \(0\)\
\-\ on\\:\\ 0\\.008133606880510428\ \(0\)\
\-\ and\\:\\ 0\\.008090292392459257\ \(0\)\
\-\ is\\:\\ 0\\.0063178739144351195\ \(0\)\
\-\ \\,\\:\\ 0\\.006083372258815447\ \(0\)\
\-\ a\\:\\ 0\\.00445617754852361\ \(0\)\
\-\ \\.\\:\\ 0\\.0019943559605250715\ \(0\)\
\-\ with\\:\\ 0\\.0013146536639313453\ \(0\)\
\-\ of\\:\\ 0\\.0013090314696403195\ \(0\)\
